Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AnaptysBio Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ANAB
Nasdaq
8731
https://www.anaptysbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AnaptysBio Inc
Industry Analysts Just Made A Stunning Upgrade To Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts
- Mar 18th, 2024 10:32 am
What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock
- Mar 14th, 2024 4:00 pm
Wall Street Analysts Believe AnaptysBio, Inc. (ANAB) Could Rally 69.62%: Here's is How to Trade
- Mar 14th, 2024 1:55 pm
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
- Mar 14th, 2024 1:40 pm
AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates
- Mar 11th, 2024 9:30 pm
Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Mar 11th, 2024 8:15 pm
Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out for
- Feb 29th, 2024 3:00 pm
Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting
- Feb 29th, 2024 2:15 pm
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?
- Feb 28th, 2024 3:00 pm
13 Best Short Squeeze Stocks To Buy Now
- Feb 22nd, 2024 9:00 am
Strength Seen in AnaptysBio, Inc. (ANAB): Can Its 5.9% Jump Turn into More Strength?
- Feb 19th, 2024 10:54 am
Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength?
- Feb 12th, 2024 7:29 am
Anaptys to Present at Guggenheim’s 6th Annual Biotechnology Conference
- Jan 31st, 2024 2:15 pm
AnaptysBio Inc CEO Daniel Faga Sells 6,866 Shares
- Jan 12th, 2024 8:02 pm
Sarepta (SRPT) Rises on Solid Q4 and 2023 Preliminary Results
- Jan 9th, 2024 3:52 pm
Corcept (CORT) Stock Rises on Upbeat Revenue Guidance for 2024
- Jan 9th, 2024 3:48 pm
Are Medical Stocks Lagging Acadia Healthcare (ACHC) This Year?
- Jan 8th, 2024 2:40 pm
AnaptysBio (NASDAQ:ANAB) shareholders have endured a 66% loss from investing in the stock five years ago
- Dec 27th, 2023 10:14 am
Does AnaptysBio, Inc. (ANAB) Have the Potential to Rally 69.36% as Wall Street Analysts Expect?
- Dec 7th, 2023 2:55 pm
Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Portfolio from Centessa Pharmaceuticals
- Nov 27th, 2023 9:15 pm
Scroll